ClinicalTrials.gg
RecruitingNCT06914622EMPOWER-RESUpdated Nov 3, 2026

Real-time Experiences, Physical Activity and Biological Outcomes in Personal Recovery Residents (EMPOWER-RES)

An interventional study of Mental Health Recovery Star (MHRS) in Severe Mental Disorder and Severe Mental Illness, sponsored by IRCCS Centro San Giovanni di Dio Fatebenefratelli. Recruiting at 3 sites in Italy. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-03.

Sponsored by IRCCS Centro San Giovanni di Dio Fatebenefratelli · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jan 2026; still recruiting 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
72
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

The project focuses on patients with severe mental disorders (SMD) residing in Italian mental health supported accommodation (SA). Although the goal of SA is to promote personal recovery - that is, living life to the fullest of one's potential - international literature on this topic is scarce, and traditional treatments in the Italian residential system show limitations in adopting such approaches.

The research hypothesis is that activating personal recovery pathways could improve the biopsychosocial outcomes of patients, caregivers, and professionals. To test this hypothesis, a non-pharmacological, non-randomized interventional trial will compare two groups: one group of individuals with SMD receiving recovery-oriented treatment, using the Mental Health Recovery Star, and another group of individuals with SMD receiving standard treatment.

The Mental Health Recovery Star is a ten-pointed star-shaped tool that represents various life dimensions. Patients, together with their key professional, are expected to negotiate a score for each domain on the five-stage 'Scale of Change,' capturing and monitoring the different phases of the recovery process.

Read the detailed description

Interventional Study Design Primary Purpose Treatment: A personal recovery-oriented intervention is being evaluated for treating people with severe mental disorders living in mental health supported accommodations Study Phase

The project will last three years and will follow these phases:

  • Phase 1: Ethical committee approval, development of the assessment manual, and training sessions for professionals. Preparation of entry and exit questionnaires for clinical and biological data collection. Establishing procedures for biological sample preparation, storage, and shipment. Conducting focus groups with patients to develop ESM questions. Setting up digital platforms and acquiring necessary materials and software. (0-8 months)
  • Phase 2: Recruitment of patients, professionals, and informal caregivers at participating centers. (7-24 months)
  • Phase 3: Clinical assessments and collection of biological and digital data at baseline. (7-24 months)
  • Phase 4: Follow-up clinical assessments and collection of biological and digital data after six and nine months. (13-30 months)
  • Phase 5: Implementation of a recovery-oriented treatment approach. (7-30 months)
  • Phase 6: Supervision meetings to ensure the correct use of assessment tools. (7-30 months)
  • Phase 7: Preliminary reports on interim findings, including sample description, correlation between personal recovery data and clinical variables, and initial analysis of biological and digital data. (24-30 months)
  • Phase 8: Data analysis and dissemination of results through conferences, workshops, and publications. (24-36 months) Interventional Study Model Parallel: Participants are assigned to one of two or more groups in parallel for the duration of the study Model Description A group of residents receiving a personal recovery-oriented treatment (N=36) will be compared to a matched group of residents receiving standard treatment (N=36). Patients in the recovery-oriented treatment group will be those whose assigned professionals have completed specific training on personal recovery.

Patients will be matched based on sex, age range (e.g., 18-25, 26-40, 41-60, 61-70), and diagnostic group according to the DSM-5-TR (schizophrenia spectrum disorders, mood disorders, personality disorders, other). Regardless of the number of patients recruited for each diagnostic category, all patients will be included in the sample, as literature indicates that residing in a specific type of residential facility makes them comparable in terms of functioning and care needs.

Assessments will be conducted at baseline (BL) and at two follow-up time points: six months and nine months (FU).

Number of Arms Two arms. Masking No masking Allocation Nonrandomized: Participants are expressly assigned to intervention groups through a non-random method, such as those whose assigned professionals have completed or not a specific training on personal recovery.

Enrollment 72 participants: 36 for the experimental group and 36 for the control group.

02

Conditions studied

  • Severe Mental Disorder
  • Severe Mental Illness

Browse trials for

Keywords

  • mental health supported accommodation
  • personal recovery
  • severe mental disorder
  • bio-psychosocial
  • rehabilitation
03

In context

Mental Disorders

1,746 studies on the registry are indexed under Mental Disorders; 350 are open to participants now.

This study's planned enrollment of 72 is below the median of 100 across 1,305 interventional studies indexed under Mental Disorders.

Browse Mental Disorders studies →

Lead sponsor

IRCCS Centro San Giovanni di Dio Fatebenefratelli is the lead sponsor of 36 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

The study population will include:

Patients with a mental disorder inclusion criteria:

  • diagnosis of a mental disorder according to DSM5TR,
  • receiving treatment at an SRP of the recruiting centers,
  • over 18 years old, willing to participate exclusion criteria:
  • moderate/severe intellectual disability,
  • inability to speak and write in Italian.

Informal caregivers of patients inclusion criteria:

  • over 18 years old,
  • willing to participate, exclusion criteria:
  • inability to speak and write in Italian.

Mental health professionals inclusion criteria:

  • working in SRPs of the recruiting centers as a psychiatrist, educator, nurse, social worker, OSS, ASA, or TeRP,
  • if part of the "personal recovery-oriented treatment" group, having specific training, exclusion criteria:
  • unwillingness to participate.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
72 participants (estimated)

Study arms

  • Experimental
    Recovery-oriented treatment

    A group of residents will receive a personal recovery-oriented treatment (N=36) whose key professionals have participated in specific training on personal recovery.

    Behavioral: Mental Health Recovery Star (MHRS)

  • No intervention
    Standard treatment

    A group of residents will receive standard treatment (N=36). Standard residential treatment for individuals with mental disorders includes medical, psychological, and social interventions aimed at improving symptoms, quality of life, and functioning. The approach is personalized based on the individual's diagnosis, symptoms, and community resources. Most SAs offer personalized care plans, designated key professionals, regular individual and group activities, medication management support, and healthy lifestyle promotion. However, few facilities provide continuous psychological, vocational, and social support, adequately addressing patients' real needs.

Interventions

  • BehavioralMental Health Recovery Star (MHRS)

    The personal recovery-oriented treatment is the Mental Health Recovery Star (MHRS), a recovery-oriented tool developed in England to support and monitor personal recovery. It features a 10-point star representing life dimensions grouped into four areas: health, functioning, self-image, and social networks. Residents assess their progress on each point using a "Scale of Change " with five recovery stages, from feeling stuck to self-reliance. After assessment, residents and professionals set recovery goals (up to three at a time) and create a shared care plan. The MHRS shows good psychometric properties, with strong validity, consistency, and ease of use, despite some inter-rater reliability issues. It is best suited for shared rehabilitation plans rather than clinical monitoring. Peer review meetings will be provided. The personal recovery-oriented treatment will last six months and will be considered complete upon follow-up evaluation.

06

What researchers measure

Primary outcomes

  1. Psychosocial functioning

    Personal and Social Functioning Scale (FPS): assesses four key domains (socially useful activities, personal and social relationships, self-care and hygiene, and disruptive/aggressive behaviors) with scores ranging from 0 to 100, where higher scores indicate better functioning.

    Time frame: at baseline and at 6 and 9 months follow-up

Secondary outcomes

  1. Rehabilitation goals

    Valutazione delle Attività e Definizione degli Obiettivi (VADO) \[Assessment of Activities and Goal Setting\]: Includes the Rehabilitation Areas Module (28 items, rated on a 4-point Likert scale), where higher scores indicate higher professional interventions.

    Time frame: at baseline and at 6-9 months follow-up

  2. Stress-related parameters

    Biological changes related to stress will be assessed through the collection of saliva samples (for three consecutive days) and blood samples to investigate High-sensitivity CRP, and pro-inflammatory cytokines IL-6, TNF-alpha, IL-1, IL-4, IL-10, hormone panel (Testosterone, E2, FSH, LH, SHBG, P4, PRL), concentration and size of extracellular vesicles (EVs).

    Time frame: at baseline and at 6-9 months follow-up

  3. Real-time experiences

    A focus group with the patients will be conducted to collaboratively define the questions for the Experience Sampling Method (ESM) questionnaire about psychopathology, involvement in productive activities, diet, use of social media, and interpersonal relationships. Data will be explored ecologically, in real-time, and longitudinally through a custom-designed app for the project, which will send daily notifications with a brief questionnaire to be developed and administered to patients via mobile app.

    Time frame: at baseline and at 6-9 months follow-up for 1 week, and partly for 6 months along the experimental or control treatment

  4. Physical Activity-Related Parameters

    Changes in physical activity will be assessed using an accelerometer (worn for one week)

    Time frame: for 1 week at baseline and at 6-9 months follow-up

  5. Working alliance

    The working alliance between patients and mental health professionals will be assessed using the Working Alliance Scale (WAI 41) at BL and FU.

    Time frame: at baseline and at 6-9 months follow-up

  6. Psychopathology

    Brief Psychiatric Rating Scale (BPRS): Evaluates psychopathology severity through 24 items rated on a 7-point Likert scale, covering five symptom categories (depression/anxiety, excitement, positive symptoms, negative symptoms, and cognitive symptoms). Higher scores indicate greater symptom severity.

    Time frame: at baseline and at 6-9 months follow-up

  7. Psychipathology and fucntioning in residential facility

    Health of the Nation Outcome Scale - Residential Facility (HoNOS-RF): Measures personal and interpersonal functioning, environment, medical aspects, cognitive problems, and psychiatric symptoms. The 33 items are rated on a 0-4 Likert scale (higher scores indicate greater severity).

    Time frame: at baseline and at 6-9 months follow-up

  8. Needs for care

    Camberwell Assessment of Need (CAN): Evaluates needs for care through a 22-item interview for both staff (CAN-S) and patients (CAN-P), rated on a 3-point scale (0 = no problem, 1 = problem managed with intervention, 2 = unmet need).

    Time frame: at baseline and at 6-9 months follow-up

  9. Functional autonomy in residential facility

    Monitoring of Pathway of Rehabilitation (MPR): Assesses functional autonomy across 10 skill areas (self-care, living space maintenance, nutrition, orientation/movement, other autonomies, social skills, socio-recreational abilities, occupational skills, health management). Scores range from 0 to 12, with higher scores indicating greater functional autonomy.

    Time frame: at baseline and at 6-9 months follow-up

  10. Personal recovery -short

    Hope, Agency and Opportunity (HAO): A 4-item questionnaire monitoring personal recovery, with higher scores indicating more favorable recovery outcomes.

    Time frame: at baseline and at 6-9 months follow-up

  11. Personal recovery

    Recovery Assessment Scale - Domains and Stages (RAS-DS): Measures personal recovery through four key areas (hope and optimism, sense of belonging and social support, life goals and future orientation, illness management and coping skills) and five stages reflecting progress in the recovery process.

    Time frame: at baseline and at 6-9 months follow-up

  12. Quality of life and exploitation

    Manchester Short Assessment of Quality of Life (MANSA): explores the patient's perception about its living situation and health. Higher scores reflect better quality of life.

    Time frame: at baseline and at 6-9 months follow-up

  13. Perceived functioning/disability

    WHO Disability Assessment Schedule (WHODAS 2.0): Evaluates perceived functioning through a 12-item scale rated on a 5-point Likert scale, with higher scores indicating greater disability.

    Time frame: at baseline and at 6-9 months follow-up

  14. Stigma

    Discrimination and Stigma Scale - Ultra Short (DISC-US): Measures perceived stigma through an 11-item questionnaire rated on a 4-point Likert scale, where higher scores indicate greater perceived discrimination.

    Time frame: at baseline and at 6-9 months follow-up

  15. Perceived loneliness

    UCLA Loneliness Scale: A 20-item scale measuring perceived loneliness, rated on a 4-point Likert scale, with higher scores indicating greater loneliness.

    Time frame: at baseline and at 6-9 months follow-up

  16. Therapeutic alliance

    Working Alliance Inventory - Short Form (WAI): Assesses therapeutic alliance using 12 items rated on a 7-point Likert scale, where higher scores indicate a stronger alliance.

    Time frame: at baseline and at 6-9 months follow-up

  17. Service satisfaction

    Verona Service Satisfaction Scale - Residential Facilities (VSSS-RF): Measures service satisfaction from the patient's and informal caregiver perspective using a 24-item questionnaire rated on a 5-point Likert scale, covering overall satisfaction, staff competence, intervention effectiveness, information, access, and family involvement.

    Time frame: at baseline and at 6-9 months follow-up

  18. Burnout Assessment Tool (BAT)

    Burnout Assessment Tool (BAT): The BAT is a psychometrically valid tool, recently developed and not subject to a paid license, making it more accessible for non-profit multicenter studies.

    Time frame: at baseline and at 6- 9 months follow-up

  19. Perceived stress

    Perceived Stress Scale (PSS): A 10-item self-report questionnaire measuring perceived stress over the last 30 days.

    Time frame: at baseline and at 6-9 months follow-up

  20. Job satisfaction

    Ad-hoc questionnaire: Evaluates job satisfaction. 11 items. higher scores indicate greater job satisfaction.

    Time frame: at baseline and at 6-9 months follow-up

  21. Distress

    Patient Health Questionnaire-4 (PHQ-4): A 4-item screening tool for anxiety and depression symptoms, with higher scores indicating greater distress and functional impairment.

    Time frame: at baseline and at 6-9months follow-up

  22. Experiences of caregiving

    Positive Aspects of Caregiving (PAC): Measures the positive experiences and benefits of caregiving, including feelings of usefulness, appreciation, and meaning in the caregiving relationship.

    Time frame: at baseline and at 6-9 months follow-up

  23. Circadian rythm- related parameters

    Changes in circadian rythm will be assessed using an accelerometer

    Time frame: one week at baseline and at 6-9 months follow-up

  24. Specific Levels of Functioning Scale (SLOF)

    Specific Levels of Functioning Scale (SLOF): Assesses psychosocial functioning. It consists of 43 items rated on a 5-point Likert scale, with total scores ranging from 43 to 215, where higher scores indicate better psychosocial functioning.

    Time frame: at baseline and at 6 and 9 months follow-up

  25. Triadic Interaction, aAliance, and Dynamic evaluation (TRIADE)

    Triadic Interaction, aAliance, and Dynamic evaluation (TRIADE): tool for assessing the alliance and reciprocal influence within the triadic care system (25 items, 1-7 likert scale; higher scores indicate stronger influence; validation ongoing)

    Time frame: at baseline and at 6 and 9 months follow-up

  26. Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)

    Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Assesses cognitive functions through 12 subtests grouped into 5 index scores. Scores below the mean indicate cognitive difficulties or possible impairment.

    Time frame: at baseline and at 6-9 months follow-up

  27. Resilience Scale - 14 item (RS-14):

    Resilience Scale - 14 item (RS-14): Measures personal resilience across 14 items; higher scores indicate greater resilience.

    Time frame: at baseline and at 6 and 9 months follow-up

  28. Quality Indicator for Rehabilitative Care - Short Assessment (QuIRC-SA)

    Time frame: once in 6 months from the baseline

  29. WHO Quality of Life-Brief scale (WHOQOL-Brief)

    WHO Quality of Life-Brief scale (WHOQOL-Brief): Assesses quality of life (26 items, 4 domains, 5-point Likert scale, range 0-100; higher scores indicate better quality of life).

    Time frame: at baseline and at 6 and 9 months follow-up

  30. Zarit Burden Interview (ZBI)

    Zarit Burden Interview (ZBI): Measures caregiver burden (29 items, 6 domains, 0-4 Likert scale; higher scores indicate greater burden).

    Time frame: at baseline and at 6 and 9 months follow-up

07

Study locations

3 of 3 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — To promote open, transparent, and collaborative science, the raw data from all studies conducted at the IRCCS Fatebenefratelli will be published in publicly accessible repositories, as required by the scientific community and funding bodies, including the Ministry of Health and the European Commission. The raw clinical and biological data related to participants in this research, a non-randomized multicenter non-pharmacological clinical trial, will be published in a form that ensures the protection of participants' privacy in accordance with current regulations. Repositories will be selected that allow access to the information only after authentication of the access request and validation by the study responsible (or a designated representative) of the reasons for the request. The public repository will also be chosen based on the cybersecurity and data protection guarantees it offers.

Supporting information: Study protocol

Time frame: From December 2028 to Dcember 2029

Access criteria: De-identified clinical and biological data from this non-randomized multicenter trial will be available in secure public repositories to support open science. Eligibility: Access is granted for research aligned with study objectives, including secondary and meta-analyses. Requests must detail statistical methods, subject to independent review. Privacy \& Security: Data will comply with protection regulations, stored only in repositories with strong cybersecurity measures. Access Process: Researchers must submit a formal request and sign a Data Sharing Agreement (DSA) before access is granted. Authentication via the repository's system is required. Review \& Approval: Requests will be evaluated by the study lead (or representative) based on scientific merit, ethical compliance, and feasibility.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2026 (actual). Primary completion is estimated for Dec 2027, 23 months after the start.

Of 668 non-industry interventional studies with no phase under Mental Disorders, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 45. This study's planned 23 months is below that.

Counting every sponsor, half of 682 studies reached it within 29 months; a quarter within 13 and three quarters within 45.

Mental Disorders covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 24, 2025
First posted
Apr 6, 2025
StartActual
Jan 15, 2026
Primary completionEst.
Dec 31, 2027
CompletionEst.
Dec 31, 2028
Last update
Nov 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Minor edits
Nothing that changes what the study is or who can join. Edited: date precision
1 update, last Nov 3, 2026
Show all 1 update
  1. Nov 3, 2026
    Minor edits only
    + 1 other change: date precision

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06914622
Lead sponsor
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Responsible party
Alessandra Martinelli (MD PhD Psychiatrist and clinical researcher, IRCCS Centro San Giovanni di Dio Fatebenefratelli) — Principal investigator
First posted
Apr 6, 2025
Start date
Jan 15, 2026
Primary completion
Dec 31, 2027 (estimated)
Completion
Dec 31, 2028 (estimated)
Last update
Nov 3, 2026

Study contacts

Alessandra Martinelli, MD PhD
Contact
amartinelli@fatebenefratelli.eu
+39 030 3501460
Amalia Research Office Manager, Morelli
Contact
amorelli@fatebenefratelli.eu
Alessandra Martinelli, MD PhD
principal investigator · IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion